We did not perform subgroup analyses in this study due to the small sample size, but the survival curves showed a trend toward separation, and it is possible that meaningful final results will emerge after expanding the database and increasing the follow-up time.
← all excerpts
Efficacy and safety of utidelone plus capecitabine in advanced first-line therapy for metastatic breast cancer: A multicenter real-world study.
1
—
—